What are the major opportunities in the Congenital Heart Disease (CHD) market? What are the strategies for the Congenital Heart Disease (CHD) market?

For detailed insights on the major opportunities and strategies in the Congenital Heart Disease (CHD) market, Read More

How does the Congenital Heart Disease (CHD) market relate to the overall economy and other similar markets?

For detailed insights on Congenital Heart Disease (CHD)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Congenital Heart Disease (CHD) market growth? SWOT analysis of the Congenital Heart Disease (CHD) market.

For detailed insights on the key dynamics influencing the Congenital Heart Disease (CHD) market growth and SWOT analysis of the Congenital Heart Disease (CHD) industry, Read More

Congenital Heart Disease (CHD) Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Congenital Heart Disease (CHD) Market Report 2026

Name: Congenital Heart Disease (CHD) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types), By Diagnosis (Electrocardiogram, Chest X-ray, Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis), By Treatment (Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications), By Age Group (Infants, Children, Adolescents, Adults), By Application (Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Congenital Heart Disease (CHD) Market Overview

• Congenital Heart Disease (CHD) market size has reached to $4.85 billion in 2025

• Expected to grow to $7.27 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%

• Growth Driver: Maternal Diabetes Driving Congenital Heart Disease Market Growth

• Market Trend: Innovative Non-Surgical Heart Valves Transforming Congenital Heart Disease Treatment

• North America was the largest region in 2025.

What Is Covered Under Congenital Heart Disease (CHD) Market?

Congenital heart disease (CHD) refers to a range of birth defects affecting the structure and function of the heart that are present at birth. These defects can involve the walls of the heart, the valves of the heart, and the arteries and veins near the heart. The treatment for CHD depends on the type and severity of the defect and may include medications, catheter-based interventions, open-heart surgery, or heart transplantation.

The main types of congenital heart disease (CHD) are heart valve defects, heart wall defects, blood vessel defects, and others. Heart valve defects refer to abnormalities or malfunctions in the heart valves, which regulate blood flow through the heart. They can be diagnosed by electrocardiogram, chest X-ray, echocardiogram, transesophageal echocardiogram, pulse oximetry, exercise stress test, Cardiac computed tomography (CT) scan or magnetic resonance imaging (MRI), cardiac catheterization, other diagnosis and treatment include interventional cardiology, cardiac surgery, telemedicine, medication management, and lifestyle modifications. The age groups include infants, children, adolescents, and adults, who are treated in hospitals and clinics, diagnostic centers, ambulatory surgical centers, research and academic institutions applications.

Congenital Heart Disease (CHD) Market Global Report 2026 Market Report bar graph

What Is The Congenital Heart Disease (CHD) Market Size and Share 2026?

The congenital heart disease (chd) market size has grown strongly in recent years. It will grow from $4.85 billion in 2025 to $5.32 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to high prevalence of structural birth defects, limited early diagnostic capabilities, reliance on open-heart surgery, high infant mortality rates, concentration of care in tertiary hospitals.

What Is The Congenital Heart Disease (CHD) Market Growth Forecast?

The congenital heart disease (chd) market size is expected to see strong growth in the next few years. It will grow to $7.27 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to advancements in minimally invasive cardiology, improved imaging and diagnostics, growing adult chd population, expansion of specialized cardiac centers, rising healthcare investments. Major trends in the forecast period include growth in early prenatal and neonatal screening, rising adoption of catheter-based interventions, expansion of pediatric and adult chd care programs, increasing survival rates driving adult chd care, multidisciplinary long-term disease management.

Book your 30 minutes free consultation with our research experts

Global Congenital Heart Disease (CHD) Market Segmentation

1) By Type: Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types

2) By Diagnosis: Electrocardiogram, Chest X-ray, Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis

3) By Treatment: Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications

4) By Age Group: Infants, Children, Adolescents, Adults

5) By Application: Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions

Subsegments:

1) By Heart Valve Defects: Aortic Valve Stenosis, Pulmonary Valve Stenosis, Mitral Valve Prolapse, Tricuspid Valve Defects, Valve Regurgitation

2) By Heart Wall Defects: Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Atrioventricular Septal Defect (AVSD), Hypoplastic Left Heart Syndrome (HLHS), Tetralogy of Fallot (TOF)

3) By Blood Vessel Defects: Coarctation Of The Aorta, Patent Ductus Arteriosus (PDA), Pulmonary Artery Stenosis, Transposition Of The Great Arteries (TGA), Truncus Arteriosus

4) By Other Types: Single Ventricle Defects, Ebstein’s Anomaly, Total Anomalous Pulmonary Venous Return (TAPVR), Coronary Artery Anomalies, Pulmonary Venous Obstruction

What Is The Driver Of The Congenital Heart Disease (CHD) Market?

The increase in maternal diabetes cases is expected to propel the growth of the congenital heart disease (CHD) market going forward. Maternal diabetes, or gestational diabetes mellitus (GDM), refers to diabetes that arises during pregnancy in women who did not have diabetes before conception. Maternal diabetes is caused by changes in lifestyle, including sedentary behavior and unhealthy dietary habits, and an overall rise in obesity rates among women of childbearing age. Maternal diabetes can lead to congenital heart disease (CHD) in infants due to the high blood sugar levels affecting fetal heart development. The elevated glucose levels in the mother's blood can disrupt the normal development of the baby's heart, increasing the risk of CHD. For instance, in November 2025, according to the Society For Maternal Fetal Medicine, a US-based organisation, gestational diabetes mellitus (GDM) impacts approximately 15.6% of women worldwide, with an estimated 23.3 million live births affected by hyperglycemia during pregnancy in 2024. Therefore, the increase in maternal diabetes cases is driving the growth of the congenital heart disease (CHD) industry.

Key Players In The Global Congenital Heart Disease (CHD) Market

Major companies operating in the congenital heart disease (chd) market are Abbott Laboratories, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Carestream Health, Schiller AG, BPL Medical Technologies, Bionet America Inc., Edwards Lifesciences Corporation, GE Healthcare, BIOTRONIK SE & Co KG, W L Gore & Associates Inc, Cook Medical, Lepu Medical Technology Co Ltd, Getinge AB, Merit Medical Systems Inc, Eurocor Tech GmbH, Braile Biomedica

Global Congenital Heart Disease (CHD) Market Trends and Insights

Major companies operating in the congenital heart disease market are developing non-surgical heart valves to improve patient outcomes and quality of life. Non-surgical heart valves, or transcatheter, are medical devices that treat heart valve diseases without needing traditional open-heart surgery. For instance, in February 2023, Medtronic, a US-based medical technology company, reintroduced its Harmony Transcatheter Pulmonary Valve (TPV) System. It is a groundbreaking, minimally invasive alternative to open-heart surgery for patients with congenital heart disease, specifically those with native or surgically repaired right ventricular outflow tract (RVOT) anomalies. This system is the first FDA-approved valve designed for the right side, providing a non-surgical solution for patients with severe pulmonary valve regurgitation. The Harmony TPV System received U.S. FDA approval in 2021. It was reintroduced following a voluntary recall, demonstrating Medtronic's commitment to advancing solutions for congenital heart disease patients.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Congenital Heart Disease (CHD) Market?

In May 2024, Novartis Healthcare Private Limited, a Switzerland-based pharmaceutical company partnered with Ayala Healthcare Holdings, Inc. (AC Health) and launched an Integrated Cardiovascular and Cancer Care. This partnership that aims to broaden access to innovative medicines for breast cancer, heart failure, and high cholesterol. Ayala Healthcare Holdings, Inc. (AC Health) is a Philippines-based pharma company focused on generic drugs.

Regional Outlook

North America was the largest region in the congenital heart disease (CHD) market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Congenital Heart Disease (CHD) Market?

The congenital heart disease (CHD) market consists of revenues earned by entities by providing services such as medical consultations, diagnostic tests, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The congenital heart disease (CHD) market also includes sales of cardiac implants such as pacemakers, implantable cardioverter-defibrillators (ICDs), and ventricular assist devices (VADs). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Congenital Heart Disease (CHD) Market Report 2026?

The congenital heart disease (chd) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the congenital heart disease (chd) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Congenital Heart Disease (CHD) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$5.32 billion
Revenue Forecast In 2035	$7.27 billion
Growth Rate	CAGR of 9.7% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Diagnosis, Treatment, Age Group, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Abbott Laboratories, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Carestream Health, Schiller AG, BPL Medical Technologies, Bionet America Inc., Edwards Lifesciences Corporation, GE Healthcare, BIOTRONIK SE & Co KG, W L Gore & Associates Inc, Cook Medical, Lepu Medical Technology Co Ltd, Getinge AB, Merit Medical Systems Inc, Eurocor Tech GmbH, Braile Biomedica
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Congenital Heart Disease (CHD) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Congenital Heart Disease (CHD) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Congenital Heart Disease (CHD) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Congenital Heart Disease (CHD) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Growth In Early Prenatal And Neonatal Screening

4.2.2 Rising Adoption Of Catheter-Based Interventions

4.2.3 Expansion Of Pediatric And Adult Chd Care Programs

4.2.4 Increasing Survival Rates Driving Adult Chd Care

4.2.5 Multidisciplinary Long-Term Disease Management

5. Congenital Heart Disease (CHD) Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Centers

5.3 Ambulatory Surgical Centers

5.4 Cardiac Specialty Centers

5.5 Research And Academic Institutions

6. Congenital Heart Disease (CHD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Congenital Heart Disease (CHD) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Congenital Heart Disease (CHD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Congenital Heart Disease (CHD) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Congenital Heart Disease (CHD) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Congenital Heart Disease (CHD) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Congenital Heart Disease (CHD) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Congenital Heart Disease (CHD) Market Segmentation

9.1. Global Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types

9.2. Global Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Electrocardiogram, Chest X-ray, Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis

9.3. Global Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications

9.4. Global Congenital Heart Disease (CHD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infants, Children, Adolescents, Adults

9.5. Global Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions

9.6. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Valve Defects, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Aortic Valve Stenosis, Pulmonary Valve Stenosis, Mitral Valve Prolapse, Tricuspid Valve Defects, Valve Regurgitation

9.7. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Wall Defects, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Atrioventricular Septal Defect (AVSD), Hypoplastic Left Heart Syndrome (HLHS), Tetralogy of Fallot (TOF)

9.8. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Blood Vessel Defects, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Coarctation Of The Aorta, Patent Ductus Arteriosus (PDA), Pulmonary Artery Stenosis, Transposition Of The Great Arteries (TGA), Truncus Arteriosus

9.9. Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single Ventricle Defects, Ebstein’s Anomaly, Total Anomalous Pulmonary Venous Return (TAPVR), Coronary Artery Anomalies, Pulmonary Venous Obstruction

10. Congenital Heart Disease (CHD) Market Regional And Country Analysis

10.1. Global Congenital Heart Disease (CHD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Congenital Heart Disease (CHD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Congenital Heart Disease (CHD) Market

11.1. Asia-Pacific Congenital Heart Disease (CHD) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Congenital Heart Disease (CHD) Market

12.1. China Congenital Heart Disease (CHD) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Congenital Heart Disease (CHD) Market

13.1. India Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Congenital Heart Disease (CHD) Market

14.1. Japan Congenital Heart Disease (CHD) Market Overview

14.2. Japan Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Congenital Heart Disease (CHD) Market

15.1. Australia Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Congenital Heart Disease (CHD) Market

16.1. Indonesia Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Congenital Heart Disease (CHD) Market

17.1. South Korea Congenital Heart Disease (CHD) Market Overview

17.2. South Korea Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Congenital Heart Disease (CHD) Market

18.1. Taiwan Congenital Heart Disease (CHD) Market Overview

18.2. Taiwan Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Congenital Heart Disease (CHD) Market

19.1. South East Asia Congenital Heart Disease (CHD) Market Overview

19.2. South East Asia Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Congenital Heart Disease (CHD) Market

20.1. Western Europe Congenital Heart Disease (CHD) Market Overview

20.2. Western Europe Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Congenital Heart Disease (CHD) Market

21.1. UK Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Congenital Heart Disease (CHD) Market

22.1. Germany Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Congenital Heart Disease (CHD) Market

23.1. France Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Congenital Heart Disease (CHD) Market

24.1. Italy Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Congenital Heart Disease (CHD) Market

25.1. Spain Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Congenital Heart Disease (CHD) Market

26.1. Eastern Europe Congenital Heart Disease (CHD) Market Overview

26.2. Eastern Europe Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Congenital Heart Disease (CHD) Market

27.1. Russia Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Congenital Heart Disease (CHD) Market

28.1. North America Congenital Heart Disease (CHD) Market Overview

28.2. North America Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Congenital Heart Disease (CHD) Market

29.1. USA Congenital Heart Disease (CHD) Market Overview

29.2. USA Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Congenital Heart Disease (CHD) Market

30.1. Canada Congenital Heart Disease (CHD) Market Overview

30.2. Canada Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Congenital Heart Disease (CHD) Market

31.1. South America Congenital Heart Disease (CHD) Market Overview

31.2. South America Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Congenital Heart Disease (CHD) Market

32.1. Brazil Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Congenital Heart Disease (CHD) Market

33.1. Middle East Congenital Heart Disease (CHD) Market Overview

33.2. Middle East Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Congenital Heart Disease (CHD) Market

34.1. Africa Congenital Heart Disease (CHD) Market Overview

34.2. Africa Congenital Heart Disease (CHD) Market, Segmentation By Type, Segmentation By Diagnosis, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Congenital Heart Disease (CHD) Market Regulatory and Investment Landscape

36. Congenital Heart Disease (CHD) Market Competitive Landscape And Company Profiles

36.1. Congenital Heart Disease (CHD) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Congenital Heart Disease (CHD) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Congenital Heart Disease (CHD) Market Company Profiles

36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Medtronic Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Roche Diagnostics International Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Congenital Heart Disease (CHD) Market Other Major And Innovative Companies

Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Carestream Health, Schiller AG, BPL Medical Technologies, Bionet America Inc., Edwards Lifesciences Corporation, GE Healthcare, BIOTRONIK SE & Co KG, W L Gore & Associates Inc, Cook Medical

38. Global Congenital Heart Disease (CHD) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Congenital Heart Disease (CHD) Market

40. Congenital Heart Disease (CHD) Market High Potential Countries, Segments and Strategies

40.1 Congenital Heart Disease (CHD) Market In 2030 - Countries Offering Most New Opportunities

40.2 Congenital Heart Disease (CHD) Market In 2030 - Segments Offering Most New Opportunities

40.3 Congenital Heart Disease (CHD) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Congenital Heart Disease (CHD) Market, Overview Of Key Products - Product Examples

Table 2: Global Congenital Heart Disease (CHD) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Congenital Heart Disease (CHD) Market, Supply Chain Analysis

Table 4: Global Congenital Heart Disease (CHD) Market, Major Raw Material Providers

Table 5: Global Congenital Heart Disease (CHD) Market, Major Resource Providers

Table 6: Global Congenital Heart Disease (CHD) Market, Major Manufacturers (Suppliers)

Table 7: Global Congenital Heart Disease (CHD) Market, Major Distributors And Channel Partners

Table 8: Global Congenital Heart Disease (CHD) Market, Key Technologies & Future Trends

Table 9: Global Congenital Heart Disease (CHD) Market, Major Trends

Table 10: Global Congenital Heart Disease (CHD) Market, Major End Users

Table 11: Global Congenital Heart Disease (CHD) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Congenital Heart Disease (CHD) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Congenital Heart Disease (CHD) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Congenital Heart Disease (CHD) Market - TAM, US$ Billion, 2025

Table 15: Global Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Congenital Heart Disease (CHD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Valve Defects, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Wall Defects, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Blood Vessel Defects, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Congenital Heart Disease (CHD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Congenital Heart Disease (CHD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Congenital Heart Disease (CHD) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Congenital Heart Disease (CHD) Market - Company Scoring Matrix

Table 100: Abbott Laboratories Financial Performance

Table 101: Medtronic Financial Performance

Table 102: Siemens Healthineers Financial Performance

Table 103: Philips Healthcare Financial Performance

Table 104: Roche Diagnostics International Ltd. Financial Performance

Table 105: Global Congenital Heart Disease (CHD) Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Congenital Heart Disease (CHD) Market, Competitive Dashboard

Table 107: Global Congenital Heart Disease (CHD) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Congenital Heart Disease (CHD) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 109: Global, Congenital Heart Disease (CHD) Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Table 110: Global, Congenital Heart Disease (CHD) Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

List Of Figures

Figure 1: Global Congenital Heart Disease (CHD) Market, Overview Of Key Products - Product Examples

Figure 2: Global Congenital Heart Disease (CHD) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Congenital Heart Disease (CHD) Market, Supply Chain Analysis

Figure 4: Global Congenital Heart Disease (CHD) Market, Major Raw Material Providers

Figure 5: Global Congenital Heart Disease (CHD) Market, Major Resource Providers

Figure 6: Global Congenital Heart Disease (CHD) Market, Major Manufacturers (Suppliers)

Figure 7: Global Congenital Heart Disease (CHD) Market, Major Distributors And Channel Partners

Figure 8: Global Congenital Heart Disease (CHD) Market, Key Technologies & Future Trends

Figure 9: Global Congenital Heart Disease (CHD) Market, Major Trends

Figure 10: Global Congenital Heart Disease (CHD) Market, Major End Users

Figure 11: Global Congenital Heart Disease (CHD) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Congenital Heart Disease (CHD) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Congenital Heart Disease (CHD) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Congenital Heart Disease (CHD) Market - TAM, US$ Billion, 2025

Figure 15: Global Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Congenital Heart Disease (CHD) Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Valve Defects, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Heart Wall Defects, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Blood Vessel Defects, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Congenital Heart Disease (CHD) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Congenital Heart Disease (CHD) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Congenital Heart Disease (CHD) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Congenital Heart Disease (CHD) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Congenital Heart Disease (CHD) Market - Company Scoring Matrix

Figure 100: Abbott Laboratories Financial Performance

Figure 101: Medtronic Financial Performance

Figure 102: Siemens Healthineers Financial Performance

Figure 103: Philips Healthcare Financial Performance

Figure 104: Roche Diagnostics International Ltd. Financial Performance

Figure 105: Global Congenital Heart Disease (CHD) Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Congenital Heart Disease (CHD) Market, Competitive Dashboard

Figure 107: Global Congenital Heart Disease (CHD) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Congenital Heart Disease (CHD) Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 109: Global, Congenital Heart Disease (CHD) Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030

Figure 110: Global, Congenital Heart Disease (CHD) Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Congenital Heart Defect Devices Market Report 2026 - Global Outlook – By Device Type (Catheters, Pacemakers, Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers, Implantable ...

Cardiometabolic Diseases Market Report 2026 - Global Outlook – By Type (Chronic Or Congestive Heart Failure, Hypertension, Type 2 Diabetes, Obesity), By Treatment (ACE inhibitors, Diuretics, Glucophage), By Dosage (Table...

Pediatric Heart Valve Repair And Replacement Market Report 2026 - Global Outlook – By Product (Heart Valve Repair, Mechanical Heart Valves, Bioprosthetic Heart Valves, Transcatheter Aortic Valve Implantation (TAVI)), By ...

Cardiac Valve Market Report 2026 - Global Outlook – By Type (Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves), By Position (Aortic Valve, Mitral Valve, Other Positions), By Treatment (Cardiac Val...

Pediatric Interventional Cardiology Market Report 2026 - Global Outlook – By Device Type (Closure Devices, Catheters), By Procedure (Congenital Heart Defect Closure Procedures, Balloon-Based Interventions, Transcatheter ...

Heart Attack Diagnostic Market Report 2026 - Global Outlook – By Test Type (Electrocardiogram (ECG Or EKG), Blood Tests, Echocardiogram, Coronary Catheterization (Angiogram)), By Procedure (Invasive Procedure, Non-Invasi...

Congestive Heart Failure (CHF) Market Report 2026 - Global Outlook – By Type (Systolic Heart Failure, Diastolic Heart Failure, Left-Sided Heart Failure, Right-Sided Heart Failure), By Treatment (Medication, Surgery), By ...

Frequently Asked Questions

What is the projected market size of the Congenital Heart Disease (CHD) Market Report 2026 market by 2030?

The Congenital Heart Disease (CHD) Market Report 2026 market was valued at $4.85 billion in 2025, increased to $5.32 billion in 2026, and is projected to reach $7.27 billion by 2030. request a sample here

What is the expected CAGR for the Congenital Heart Disease (CHD) Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Congenital Heart Disease (CHD) Market Report 2026 market during the forecast period 2025–2030 is 8.1%. request a sample here

What are the key factors driving the Congenital Heart Disease (CHD) Market Report 2026 market?

Major growth driver of the market includes: Maternal Diabetes Driving Congenital Heart Disease Market Growth in the Congenital Heart Disease (CHD) Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Congenital Heart Disease (CHD) Market Report 2026 market report?

The congenital heart disease (chd) market covered in this report is segmented –
1) By Type: Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types
2) By Diagnosis: Electrocardiogram, Chest X-ray, Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis
3) By Treatment: Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications
4) By Age Group: Infants, Children, Adolescents, Adults
5) By Application: Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions Subsegments:
1) By Heart Valve Defects: Aortic Valve Stenosis, Pulmonary Valve Stenosis, Mitral Valve Prolapse, Tricuspid Valve Defects, Valve Regurgitation
2) By Heart Wall Defects: Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Atrioventricular Septal Defect (AVSD), Hypoplastic Left Heart Syndrome (HLHS), Tetralogy of Fallot (TOF)
3) By Blood Vessel Defects: Coarctation Of The Aorta, Patent Ductus Arteriosus (PDA), Pulmonary Artery Stenosis, Transposition Of The Great Arteries (TGA), Truncus Arteriosus
4) By Other Types: Single Ventricle Defects, Ebstein’s Anomaly, Total Anomalous Pulmonary Venous Return (TAPVR), Coronary Artery Anomalies, Pulmonary Venous Obstruction request a sample here

What is the anticipated growth trend for the Congenital Heart Disease (CHD) Market Report 2026 market?

Major trend in this market includes: Innovative Non-Surgical Heart Valves Transforming Congenital Heart Disease Treatment For further insights on this market, request a sample here.

Who are the key players in the Congenital Heart Disease (CHD) Market Report 2026 market?

Major companies operating in the Congenital Heart Disease (CHD) Market Report 2026 market are Major companies operating in the congenital heart disease (chd) market are Abbott Laboratories, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Carestream Health, Schiller AG, BPL Medical Technologies, Bionet America Inc., Edwards Lifesciences Corporation, GE Healthcare, BIOTRONIK SE & Co KG, W L Gore & Associates Inc, Cook Medical, Lepu Medical Technology Co Ltd, Getinge AB, Merit Medical Systems Inc, Eurocor Tech GmbH, Braile Biomedica request a sample here.

Which region has the most growth potential in the Congenital Heart Disease (CHD) Market Report 2026 market?

North America was the largest region in the congenital heart disease (CHD) market in 2025. The regions covered in the congenital heart disease (chd) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.